BioCentury
ARTICLE | Company News

Affitech, Isogenica antibody deal

October 1, 2001 7:00 AM UTC

Antibody play Affitech (Oslo, Norway) received an exclusive license to Covalent Display Technology (CDT) from Isogenica ( Cambridge, U.K.) for generating specific binding molecules to drug targets. Wi...